Lallemand Health Solutions and Kirin Holdings have announced a distribution partnership for Immuse, dubbed one of the most documented postbiotics for immune support, backed by patent-protected research. The clinically researched lactic acid bacteria support immune health through a unique mode of action. This heat-inactivated Lactococcus lactis strain Plasma (LC Plasma) directly activates key immune cells called plasmacytoid dendritic cells, offering comprehensive immune support by stimulating both innate and adaptive immune responses.
